Langevin, James R.
U.S. Representative RI-2 Democratic PartyCongressional stock trade history disclosed under the STOCK Act, as filed.
Latest disclosed trades
Latest 10 of 414| Ticker | Type | Traded |
|---|---|---|
| GNRC | Sell | Dec 20, 2022 |
| GNRC | Sell | Dec 12, 2022 |
| GNRC | Buy | Dec 5, 2022 |
| GNRC | Buy | Nov 29, 2022 |
| META | Sell | Nov 14, 2022 |
| ABNB | Buy | Nov 7, 2022 |
| ABNB | Sell | Nov 4, 2022 |
| DASH | Sell | Nov 4, 2022 |
| DASH | Sell | Nov 3, 2022 |
| SQ | Buy | Nov 1, 2022 |
Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window.
Langevin, James R. stock trade activity
FilingIQ has indexed 414 congressional stock trade disclosures for Langevin, James R.. The most recent disclosed transaction is dated Dec 20, 2022.
Across the full history, 200 purchases and 214 sales have been disclosed under the STOCK Act.
Top tickers traded by Langevin, James R.
Frequently asked
- How many stock trades has Langevin, James R. disclosed?
- FilingIQ tracks 414 Periodic Transaction Report disclosures for Langevin, James R., with the most recent dated Dec 20, 2022. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
- Is Langevin, James R. a net buyer or net seller?
- Across the disclosed trade history, 200 (48%) were purchases and 214 (52%) were sales. Compensation and exchanges are filtered out of these counts.
- Where does FilingIQ's data on Langevin, James R. come from?
- Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.
Methodology & sources
Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.